A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence

Alcoholism, Clinical and Experimental Research
Mary StedmanShane Raines

Abstract

This study evaluated the efficacy of quetiapine versus placebo as an adjunct to lithium or divalproex in reducing alcohol consumption in patients with bipolar I disorder and coexisting alcohol dependence. Male and female outpatients (21 to 60 years) with a history of bipolar I disorder and alcohol dependence were included in this 12-week, placebo-controlled study. Patients treated with lithium or divalproex (ongoing or assigned at screening) were randomized to receive quetiapine (dosed up to 400 mg/d over 7 days, followed by 300 to 800 mg/d flexible dosing until study end) or placebo. The primary outcome measure was the change in the proportion of heavy drinking days from baseline to Week 12 (as derived from the Timeline Followback method). Secondary outcome measures included time to the first consecutive 2 weeks of abstinence, changes from baseline to Week 12 in the proportion of nondrinking days, mean number of standardized drinks per day, and Clinical Global Impressions-Severity of Illness score. Of 362 enrolled patients (mean 38.6 years), 176 were randomized to receive quetiapine and 186 to placebo. The mean proportion of heavy drinking days at baseline was 0.66 in the quetiapine group and 0.67 in the placebo group. At Week...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jan 1, 1983·Journal of the American College of Cardiology·H T Dodge, F H Sheehan
Jun 1, 1994·The Journal of Nervous and Mental Disease·S C SonneW A Morton
Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·B GellerJ Heath
Apr 30, 1998·Journal of Substance Abuse Treatment·P F Buckley
May 20, 1998·The Journal of Clinical Psychiatry·R D WeissM L Griffin
Jan 10, 2003·Bipolar Disorders·E Sherwood BrownLeonardo Bobadilla
Mar 27, 2003·Bipolar Disorders·E Jane DaltonJames L Kennedy
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Jan 8, 2004·Journal of Clinical Psychopharmacology·Jason LongoriaVicki A Nejtek
Jul 17, 2007·Journal of Clinical Psychopharmacology·Kyle M KampmanCharles P O'Brien
Oct 3, 2007·Substance Abuse Treatment, Prevention, and Policy·Michael A Cerullo, Stephen M Strakowski

❮ Previous
Next ❯

Citations

Sep 18, 2012·Current Psychiatry Reports·Conor K FarrenRoger D Weiss
Mar 8, 2012·Current Opinion in Psychiatry·Pratima Murthy, Prabhat Chand
Dec 22, 2015·Journal of Affective Disorders·Terence A KetterPo W Wang
May 5, 2012·Expert Opinion on Pharmacotherapy·Philip G Janicak, Jeffrey T Rado
Jan 27, 2016·The American Journal of Drug and Alcohol Abuse·Heather XiaoE Sherwood Brown
Jan 19, 2016·Revista de psiquiatrí́a y salud mental·Adrián Secades-Álvarez, Concepción Fernández-Rodríguez
May 10, 2011·Drug and Alcohol Dependence·James J PrisciandaroBryan K Tolliver
Mar 12, 2015·Journal of Addictions Nursing·Tracy L HellemPerry F Renshaw
Aug 13, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Stéphanie Bourion-BédèsCédric Baumann
Jan 1, 2011·International Journal of Psychiatry in Medicine·Peter M MillerScott H Stewart
Dec 23, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Mar 17, 2017·The American Journal of Drug and Alcohol Abuse·Ihsan M Salloum, Edson Sherwood Brown
May 26, 2012·Journal of Psychopharmacology·A R Lingford-HughesUNKNOWN British Association for Psychopharmacology, Expert Reviewers Group
Sep 3, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Paul R A StokesAllan H Young
May 12, 2019·Bipolar Disorders·Alexandria S ColesTony P George
Apr 12, 2019·Current Opinion in Psychiatry·Pratima MurthyPrabhat K Chand
Jul 3, 2017·CNS Drugs·Andrew NaglichE Sherwood Brown
Jun 4, 2019·Current Opinion in Psychiatry·Pratima MurthyPrabhat K Chand
May 26, 2017·Advances in Therapy·Marco Di NicolaLuigi Janiri
Apr 26, 2017·European Archives of Psychiatry and Clinical Neuroscience·U W PreussK F Mann
Apr 10, 2021·Frontiers in Psychiatry·Heinz GrunzeUlrich W Preuss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.